Rapid antibody responses by low-dose, single-step, dendritic cell-targeted immunization

被引:76
作者
Wang, H
Griffiths, MN
Burton, DR
Ghazal, P
机构
[1] Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA
[2] Scripps Res Inst, Dept Biol Mol, Div Virol, La Jolla, CA 92037 USA
关键词
D O I
10.1073/pnas.97.2.847
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
We have compared the kinetics of antibody responses in conventional and dendritic cell-targeted immunization by using a model antigen in mice. Targeting was achieved by linking the reporter antigen (polyclonal goat anti-hamster antibody) to N418, a hamster mAb that binds to the CD11c molecule on the surface of murine dendritic cells, Intradermal injection of submicrogram quantities of goat anti-hamster antibody complexed to mAb N418 elicited goat antibody-specific serum IgG in mice. Antigen-specific IgG titers were detectable by day 5, with titers that ranged from 1:1000 to 1:100,000 by day 7. In contrast, when the goat antigen was injected alone or in the presence of a hamster antibody control to form nontargeted complexes, goat-specific serum IgG was undetectable at day 7. Additional control experiments showed that the interaction between the model antigen and mAb N418 is required for amplification of the serum antibody response. These studies demonstrate that a single-step, facilitated-delivery of small amounts of protein antigen to dendritic cells in vivo can give very rapid and high antibody responses. The approach may be particularly useful for vaccination immediately before or just after exposure to a pathogen and may enhance the utility of subunit antigens as immunogens.
引用
收藏
页码:847 / 852
页数:6
相关论文
共 29 条
[1]  
Barber B H, 1997, Semin Immunol, V9, P293, DOI 10.1006/smim.1997.0085
[2]   COMPARING MACROPHAGES AND DENDRITIC LEUKOCYTES AS ANTIGEN-PRESENTING CELLS FOR HUMORAL RESPONSES IN-VIVO BY ANTIGEN TARGETING [J].
BERG, SF ;
MJAALAND, S ;
FOSSUM, S .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1994, 24 (06) :1262-1268
[3]   Why do we not have an HIV vaccine and how can we make one? [J].
Burton, DR ;
Moore, JP .
NATURE MEDICINE, 1998, 4 (05) :495-498
[4]   CHARACTERIZATION OF THE ADJUVANT-FREE SEROLOGICAL RESPONSE TO PROTEIN ANTIGENS COUPLED TO ANTIBODIES SPECIFIC FOR CLASS-II MHC DETERMINANTS [J].
CARAYANNIOTIS, G ;
BARBER, BH .
VACCINE, 1990, 8 (02) :137-144
[5]   ADJUVANT-FREE IGG RESPONSES INDUCED WITH ANTIGEN COUPLED TO ANTIBODIES AGAINST CLASS-II MHC [J].
CARAYANNIOTIS, G ;
BARBER, BH .
NATURE, 1987, 327 (6117) :59-61
[6]   ADJUVANT-INDEPENDENT IMMUNIZATION BY IMMUNOTARGETING ANTIGENS TO MHC AND NON-MHC DETERMINANTS INVIVO [J].
CARAYANNIOTIS, G ;
SKEA, DL ;
LUSCHER, MA ;
BARBER, BH .
MOLECULAR IMMUNOLOGY, 1991, 28 (03) :261-267
[7]  
ELLIS RW, 1999, VACCINES, P881
[8]   IMPORTANCE OF DOSE OF NEUTRALIZING ANTIBODIES IN TREATMENT OF ARGENTINE HEMORRHAGIC-FEVER WITH IMMUNE PLASMA [J].
ENRIA, DA ;
BRIGGILER, AM ;
FERNANDEZ, NJ ;
LEVIS, SC ;
MAIZTEGUI, JI .
LANCET, 1984, 2 (8397) :255-256
[9]   Murine dendritic cells pulsed with whole tumor lysates mediate potent antitumor immune responses in vitro and in vivo [J].
Fields, RC ;
Shimizu, K ;
Mulé, JJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (16) :9482-9487
[10]  
Finkelman FD, 1996, J IMMUNOL, V157, P1406